Nurtec ODT 75 MG tablet 8S
Ended Awarded Last action
- Contract number
- SPE2DR26F5Z29
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $43,518
Award facts
- Contract value 100% obligated
- $43,517.75 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
AmerisourceBergen Drug Corp, a subsidiary of Cencora, Inc., was awarded a delivery order valued at $43,517.75 by the Defense Logistics Agency (DLA) on January 22, 2026, for the supply of NURTEC ODT 75 mg tablets (8 count). This is a firm fixed-price, non-set-aside contract with a completion date of January 23, 2026, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award represents a task order issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical, valued at up to $999,999,999.00 through December 2026, which serves as a comprehensive vehicle for supplying pharmaceutical products and medical supplies to military healthcare programs globally.
AmerisourceBergen Drug Corp is a major pharmaceutical distributor that supplies a broad range of medications across multiple therapeutic domains to federal agencies, with demonstrated expertise in fulfilling competitive federal procurement requirements. NURTEC ODT (rimegepant) is a migraine treatment medication, and this delivery order fulfills specific medical supply needs within the Defense Health Agency's pharmaceutical procurement. The competitive awards and firm fixed-price structure reflect standard DLA Medical Supply Chain procurement practices for essential pharmaceutical commodities supporting military treatment facilities and veteran healthcare programs.
Quick answers
Who was awarded contract SPE2DR26F5Z29?
SPE2DR26F5Z29 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 22, 2026.
How much is contract SPE2DR26F5Z29 worth?
The government has obligated $43,518 on SPE2DR26F5Z29.
Is contract SPE2DR26F5Z29 an order under another contract?
Yes. SPE2DR26F5Z29 is a delivery order under SPE2DR25D3101, an indefinite delivery contract.
Was contract SPE2DR26F5Z29 competed?
The extent of competition for SPE2DR26F5Z29 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award